Bandiala, Reziel Mea A.
HRN: 25-97-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2024
CEFUROXIME 750MG (VIAL)
09/28/2024
10/04/2024
IV
750mg
Q8
URTI, AGE
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes